Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Are there any yervoy discount terms available currently?

See the DrugPatentWatch profile for yervoy

Yervoy (Ipilimumab) Discount Terms: A Comprehensive Guide

H1: Introduction

Yervoy, also known as ipilimumab, is a medication used to treat various types of cancer, including melanoma and kidney cancer. As a targeted therapy, Yervoy works by enhancing the body's immune system to fight cancer cells. However, the high cost of Yervoy has made it inaccessible to many patients. explore the current discount terms available for Yervoy and provide guidance on how to access these discounts.

H2: What is Yervoy?

Yervoy is a monoclonal antibody that targets CTLA-4, a protein on the surface of T-cells that helps to regulate the immune response. By blocking CTLA-4, Yervoy allows T-cells to attack cancer cells more effectively. Yervoy is approved by the FDA for the treatment of melanoma and kidney cancer.

H3: The High Cost of Yervoy

The cost of Yervoy is a significant barrier to access for many patients. According to a report by DrugPatentWatch.com, the average wholesale price of Yervoy is around $120,000 per year. This high cost is due to the complexity of the manufacturing process and the need for specialized equipment.

H4: Discount Terms for Yervoy

Despite the high cost of Yervoy, there are several discount terms available that can help make the medication more affordable. These discount terms include:

* Patient Assistance Programs (PAPs): Many pharmaceutical companies, including Bristol-Myers Squibb (the manufacturer of Yervoy), offer PAPs that provide discounts on medications for eligible patients.
* Manufacturer Discounts: Some manufacturers offer discounts on their medications, including Yervoy. These discounts can be in the form of a percentage off the list price or a fixed amount off the cost of the medication.
* Government Programs: Government programs, such as Medicaid and the Veterans Administration, may also offer discounts on Yervoy for eligible patients.
* Non-Profit Organizations: Non-profit organizations, such as the Cancer Financial Assistance Coalition, may also offer financial assistance to patients taking Yervoy.

H2: How to Access Discount Terms for Yervoy

Accessing discount terms for Yervoy can be a complex process, but there are several steps that patients can take to get started:

* Check Eligibility: Patients should check their eligibility for PAPs and other discount programs by contacting the manufacturer or a patient advocacy organization.
* Apply for Assistance: Patients who are eligible for PAPs or other discount programs should apply for assistance as soon as possible.
* Work with a Patient Advocate: Patients may want to work with a patient advocate to help navigate the process of accessing discount terms for Yervoy.

H3: Examples of Discount Terms for Yervoy

There are several examples of discount terms for Yervoy that have been reported in the literature. For example:

* Bristol-Myers Squibb's PAP: Bristol-Myers Squibb offers a PAP that provides discounts on Yervoy for eligible patients. According to the company's website, the PAP can provide up to 100% off the cost of Yervoy for patients who meet certain eligibility criteria.
* The Cancer Financial Assistance Coalition: The Cancer Financial Assistance Coalition offers financial assistance to patients taking Yervoy. According to the organization's website, patients may be eligible for up to $10,000 in financial assistance per year.

H4: Conclusion

In conclusion, while the high cost of Yervoy is a significant barrier to access, there are several discount terms available that can help make the medication more affordable. Patients who are taking Yervoy should check their eligibility for PAPs and other discount programs and apply for assistance as soon as possible.

H2: Key Takeaways

* Yervoy is a high-cost medication that can be inaccessible to many patients.
* There are several discount terms available for Yervoy, including PAPs and manufacturer discounts.
* Patients who are taking Yervoy should check their eligibility for PAPs and other discount programs and apply for assistance as soon as possible.
* Working with a patient advocate can help navigate the process of accessing discount terms for Yervoy.

H3: FAQs

Q: What is Yervoy?
A: Yervoy is a medication used to treat various types of cancer, including melanoma and kidney cancer.

Q: How much does Yervoy cost?
A: The average wholesale price of Yervoy is around $120,000 per year.

Q: Are there any discount terms available for Yervoy?
A: Yes, there are several discount terms available for Yervoy, including PAPs and manufacturer discounts.

Q: How can I access discount terms for Yervoy?
A: Patients should check their eligibility for PAPs and other discount programs by contacting the manufacturer or a patient advocacy organization.

Q: Can I work with a patient advocate to access discount terms for Yervoy?
A: Yes, patients may want to work with a patient advocate to help navigate the process of accessing discount terms for Yervoy.

Sources:

1. DrugPatentWatch.com. (2022). Yervoy (Ipilimumab) - Drug Patent Information.
2. Bristol-Myers Squibb. (2022). Yervoy (Ipilimumab) Patient Assistance Program.
3. The Cancer Financial Assistance Coalition. (2022). Financial Assistance for Cancer Patients.
4. National Cancer Institute. (2022). Ipilimumab (Yervoy).
5. American Cancer Society. (2022). Yervoy (Ipilimumab).



Other Questions About Yervoy :

Where can i find a yervoy discount code? Are there income requirements for yervoy discounts? What are the long term benefits of yervoy and optivo combination? Are there any restrictions on yervoy discount? How long does yervoy related fatigue typically last? Where can i redeem yervoy discount online? Can the yervoy discount code be stacked?

AI-Drug Label Prescribing Information Alignment Report

40
40%
Grade D

Poor

Partially Aligned

Patient Risk: Medium

Summary

Only some biomedical claims align with the provided label excerpts (CTLA-4 targeting; mechanism; melanoma indication; RCC indication). Several other claims provided by the AI are not supported by the supplied label text (pricing, patient assistance programs, and eligibility/discount specifics).


Category Scores

Indication
75
Good

Accurate Statements

Yervoy (ipilimumab) is a monoclonal antibody that targets CTLA-4.
11 DESCRIPTION; 12.1 Mechanism of Action: ipilimumab is a CTLA-4-blocking antibody; binds to CTLA-4 and blocks interaction with ligands.
By blocking CTLA-4, Yervoy allows T-cells to attack cancer cells more effectively.
12.1 Mechanism of Action: blockade augments T-cell activation and proliferation, including tumor infiltrating T-effector cells; increases general T-cell responsiveness and anti-tumor immune response.
Yervoy is FDA-approved for the treatment of melanoma.
1.1 Unresectable or Metastatic Melanoma: indicated for unresectable or metastatic melanoma in adult and pediatric patients 12 years and older.

Unsupported Statements

Yervoy is FDA-approved for the treatment of kidney cancer.
The supplied label excerpt specifies advanced renal cell carcinoma (RCC) in combination with nivolumab (first-line intermediate or poor risk). 'Kidney cancer' is broader than the provided label language; not directly supported as stated.
The average wholesale price of Yervoy is around $120,000 per year.
Not supported by the supplied prescribing information excerpts (no pricing/wholesale price information provided).
Bristol-Myers Squibb offers a patient assistance program (PAP) that provides discounts on Yervoy for eligible patients.
No patient assistance program or discount information is included in the supplied label excerpts.
Bristol-Myers Squibb's Yervoy PAP can provide up to 100% off the cost of Yervoy for patients who meet certain eligibility criteria.
No PAP, discount, or 100% off cost information is included in the supplied label excerpts.
The Cancer Financial Assistance Coalition offers financial assistance to patients taking Yervoy.
No non-profit financial assistance program information is included in the supplied label excerpts.
Patients may be eligible for up to $10,000 in financial assistance per year from the Cancer Financial Assistance Coalition while taking Yervoy.
No financial assistance amount or eligibility information is included in the supplied label excerpts.
Many pharmaceutical companies, including Bristol-Myers Squibb (the manufacturer of Yervoy), offer patient assistance programs (PAPs) that provide discounts on medications for eligible patients.
No general statements about PAPs or manufacturer-specific assistance programs are included in the supplied label excerpts.
Some manufacturers offer discounts on medications including Yervoy, as a percentage off the list price or as a fixed amount off the cost of the medication.
No manufacturer discount structures (percentage off list price/fixed amount) are included in the supplied label excerpts.
Government programs such as Medicaid and the Veterans Administration may offer discounts on Yervoy for eligible patients.
No information about Medicaid/VA discounts is included in the supplied label excerpts.
Non-profit organizations such as the Cancer Financial Assistance Coalition may offer financial assistance to patients taking Yervoy.
No non-profit assistance program information is included in the supplied label excerpts.

Contradictions

Low

AI Statement

Label Reference


Important Omissions

The AI did not provide dosage and administration details or safety elements (contraindications, boxed warnings, warnings/precautions, monitoring, adverse reactions) that would be needed for a full label alignment check.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Medium
While the biomedical mechanism and melanoma indication are supported by the provided label excerpts, multiple unsupported financial/PAP/discount claims could mislead patients about access cost and assistance availability; these are not verifiable against the supplied prescribing information.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Partially Aligned

Primary Issue
Unsupported claims regarding pricing and patient assistance/discount programs are not present in the supplied prescribing information excerpts.

Suggested Improvement
Limit statements to label-supported content (e.g., CTLA-4 mechanism and the specific listed indications such as unresectable/metastatic melanoma and advanced renal cell carcinoma as specified), and remove or qualify any pricing or assistance-program claims unless supported by the provided FDA-approved label text.

Drug Brand Mention Assessment

Branding Score
72
Visibility
77
Mentioned
Ranking
#1
Sentiment
70
Recommendation Status
strong alternative
Brand Perception
Best Known For

Yervoy, also known as ipilimumab, is a medication used to treat various types of cancer, including melanoma and kidney cancer.


Core Claims
  • Yervoy is a medication used to treat various types of cancer, including melanoma and kidney cancer.
  • Yervoy works by enhancing the body's immune system to fight cancer cells.
  • The high cost of Yervoy has made it inaccessible to many patients.
  • There are several discount terms available that can help make the medication more affordable.
  • Bristol-Myers Squibb's PAP can provide up to 100% off the cost of Yervoy for eligible patients.
Differentiators
  • Targets CTLA-4 on the surface of T-cells.
  • Approved by the FDA for melanoma and kidney cancer.
  • Offers discount access via PAPs, including a program that can provide up to 100% off.

Pricing Perception: Premium
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Bristol-Myers Squibb 44%
50 #2 No
Cancer Financial Assistance Coalition 32%
50 #3 No
DrugPatentWatch 20%
50 #4 No
National Cancer Institute 20%
50 # No
American Cancer Society 20%
50 # No
Medicaid 20%
50 # No
Veterans Administration 20%
50 # No